Economiic Home Method Watch Market RSI Search

Cybin Inc. CYBN

Sector:

Healthcare

Industry:

Biotechnology

Description:

Cybin Inc., a biopharmaceutical company, focuses on developing psychedelic-based therapeutics. The company's development pipeline includes CYB003, a deuterated psilocybin analog to treat major depressive and alcohol use disorders; CYB004, a deuterated dimethyltryptamine for treating anxiety disorders; and CYB005, a phenethylamine derivative to treat neuroinflammation. It has also developed EMBARK, a psychedelic-assisted psychotherapy. The company is headquartered in Toronto, Canada.
Cybin Inc. website

Recent Quarter:

2024-06-26

Upcoming Quarter:

2024-08-12

Quarterly Reports

Date2024-03-31
Revenue 0
Net Income -21,346,000
EPS -0.0281
Basic Shares 760,053,342
Diluted Shares 760,053,342
Report Link
Date2024-02-14
Revenue 0
Net Income -30,330,000
EPS -0.0909
Basic Shares 333,679,544
Diluted Shares 333,679,544
Report Link
Date2023-11-15
Revenue 0
Net Income -11,890,000
EPS -0.0507
Basic Shares 234,584,277
Diluted Shares 234,584,277
Report Link
Date2023-08-14
Revenue 0
Net Income -12,375,000
EPS -0.06
Basic Shares 206,157,780
Diluted Shares 206,157,780
Report Link
Date2023-03-31
Revenue 0
Net Income -13,720,000
EPS -0.0699
Basic Shares 196,144,381
Diluted Shares 196,144,381
Report Link
Date2023-02-14
Revenue 0
Net Income -10,742,000
EPS -0.0569
Basic Shares 188,887,344
Diluted Shares 188,887,344
Report Link
Date2022-11-15
Revenue 0
Net Income -9,973,000
EPS -0.0551
Basic Shares 180,837,176
Diluted Shares 180,837,176
Report Link
Date2022-08-08
Revenue 0
Net Income -13,055,000
EPS -0.0742
Basic Shares 175,874,475
Diluted Shares 175,874,475
Report Link
Date2022-03-31
Revenue 0
Net Income -18,097,000
EPS -0.1
Basic Shares 173,757,166
Diluted Shares 173,757,166
Report Link
Date2021-08-16
Revenue 0
Net Income -14,717,000
EPS -0.0933
Basic Shares 157,711,518
Diluted Shares 157,711,518
Report Link
Date2021-03-31
Revenue -138
Net Income -13,778,164
EPS -0.0874
Basic Shares 157,454,415
Diluted Shares 157,711,518
Report Link
Date2020-12-31
Revenue 0
Net Income -11,418,721
EPS -0.1
Basic Shares 110,223,000
Diluted Shares 110,223,000
Report Link
Date2020-10-31
Revenue 0
Net Income -48,897
EPS -0.0004
Basic Shares 131,278,549
Diluted Shares 131,278,549
Report Link
Date2020-06-30
Revenue 864,000
Net Income -4,363,000
EPS -0.0332
Basic Shares 131,278,549
Diluted Shares 131,278,549
Report Link

Quarterly Ratios

Date2024-03-31
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2023-12-31
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2023-09-30
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2023-06-30
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2023-03-31
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2022-12-31
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2022-09-30
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2022-06-30
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2022-03-31
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2021-06-30
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2021-03-31
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2020-12-31
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2020-10-31
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2020-06-30
Dividend Yield 0.00
Payout Ratio: 0.000%

Annual Reports

Date2024-03-31
Revenue 0
Net Income -78,080,000
EPS -0.1
Basic Shares 760,053,342
Diluted Shares 760,053,342
Report Link
Date2023-03-31
Revenue 0
Net Income -40,037,000
EPS -0.22
Basic Shares 185,428,767
Diluted Shares 185,428,767
Report Link
Date2022-03-31
Revenue 0
Net Income -71,424,000
EPS -0.43
Basic Shares 167,287,240
Diluted Shares 167,287,240
Report Link
Date2021-03-31
Revenue 864,000
Net Income -32,220,000
EPS -0.32
Basic Shares 100,010,864
Diluted Shares 100,010,864
Report Link
Date2020-03-31
Revenue 0
Net Income -1,944,000
EPS -0.048
Basic Shares 40,500,000
Diluted Shares 49,976,788
Report Link
Date2019-07-31
Revenue 0
Net Income -100,524
EPS -0.0072
Basic Shares 13,886,302
Diluted Shares 13,886,302
Report Link

Annual Ratios

Date2024-03-31
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2023-03-31
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2022-03-31
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2021-03-31
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2020-03-31
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2019-07-31
Dividend Yield 0.00
Payout Ratio: 0.000%

RSI:

42.47

Price:

$0.29

Market Cap:

216,816,097

EPS TTM:

-0.23

PE Ratio:

-3.97

PEPSG:

NaN

Volume:

4,306,065

2 Year Price Change

0.529

Index 2 Year Price Change

1.357

5 Year Price Change

No Price 5 Years Ago

Index 5 Year Price Change

1.804
PESPG: Growth Rate of EPS projected to next quarter and 6 months trailing. Lower is better to help calculate nexts quarters PE Ratio today. Diluted shares effects the EPS reported and makes calculation show as extremely poor expected growth.

News

Press Releases

Notable Earnings

Please select an option: